Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	postsynaptic density	MAP1B PCLO GRIN2A PIP5K1C RYK NEFM DST SIPA1L1 OLFM1 MACF1 DCLK1	9.15e-05	451	126	11	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	MAP1B PCLO GRIN2A PIP5K1C RYK NEFM DST SIPA1L1 OLFM1 MACF1 DCLK1	1.50e-04	477	126	11	GO:0032279
GeneOntologyCellularComponent	DNA polymerase complex	POLE MCM3 REV3L	2.26e-04	20	126	3	GO:0042575
GeneOntologyCellularComponent	postsynaptic specialization	MAP1B PCLO GRIN2A PIP5K1C RYK NEFM DST SIPA1L1 OLFM1 MACF1 DCLK1	2.37e-04	503	126	11	GO:0099572
GeneOntologyCellularComponent	neuron to neuron synapse	MAP1B PCLO GRIN2A PIP5K1C RYK NEFM DST SIPA1L1 OLFM1 MACF1 DCLK1	3.30e-04	523	126	11	GO:0098984
GeneOntologyCellularComponent	katanin complex	KATNAL1 KATNA1	3.56e-04	5	126	2	GO:0008352
GeneOntologyCellularComponent	midbody	SYNE1 KATNA1 BIRC6 SVIL ZFYVE26 PKN1 MBD5	4.02e-04	222	126	7	GO:0030496
Domain	TF_AP2	TFAP2D TFAP2E TFAP2A TFAP2C	8.91e-09	5	123	4	IPR004979
Domain	TF_AP2_C	TFAP2D TFAP2E TFAP2A TFAP2C	8.91e-09	5	123	4	IPR013854
Domain	TF_AP-2	TFAP2D TFAP2E TFAP2A TFAP2C	8.91e-09	5	123	4	PF03299
Domain	Spectrin	TRIO SYNE1 DST MACF1	1.44e-05	23	123	4	PF00435
Domain	Spectrin_repeat	TRIO SYNE1 DST MACF1	3.74e-05	29	123	4	IPR002017
Domain	KATNA1	KATNAL1 KATNA1	4.30e-05	2	123	2	IPR028596
Domain	SPEC	TRIO SYNE1 DST MACF1	5.58e-05	32	123	4	SM00150
Domain	Spectrin/alpha-actinin	TRIO SYNE1 DST MACF1	5.58e-05	32	123	4	IPR018159
Domain	DUF4683	REV3L AHDC1	1.29e-04	3	123	2	PF15735
Domain	FAM194	ERICH6B ERICH6	1.29e-04	3	123	2	IPR029281
Domain	FAM194	ERICH6B ERICH6	1.29e-04	3	123	2	PF14977
Domain	DUF4683	REV3L AHDC1	1.29e-04	3	123	2	IPR032757
Domain	DNA_pol_B	POLE REV3L	2.56e-04	4	123	2	PF00136
Domain	DNA-dir_DNA_pol_B	POLE REV3L	2.56e-04	4	123	2	IPR006172
Domain	DNA-dir_DNA_pol_B_exonuc	POLE REV3L	2.56e-04	4	123	2	IPR006133
Domain	DNA-dir_DNA_pol_B_multi_dom	POLE REV3L	2.56e-04	4	123	2	IPR006134
Domain	DNA_pol_B_exo1	POLE REV3L	2.56e-04	4	123	2	PF03104
Domain	POLBc	POLE REV3L	2.56e-04	4	123	2	SM00486
Domain	ACTININ_2	SYNE1 DST MACF1	4.48e-04	23	123	3	PS00020
Domain	ACTININ_1	SYNE1 DST MACF1	4.48e-04	23	123	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 DST MACF1	4.48e-04	23	123	3	IPR001589
Domain	-	DST MACF1	6.34e-04	6	123	2	3.90.1290.10
Domain	GAR	DST MACF1	6.34e-04	6	123	2	PS51460
Domain	GAS2	DST MACF1	6.34e-04	6	123	2	PF02187
Domain	-	DST MACF1	6.34e-04	6	123	2	3.30.920.20
Domain	GAS_dom	DST MACF1	6.34e-04	6	123	2	IPR003108
Domain	GAS2	DST MACF1	6.34e-04	6	123	2	SM00243
Domain	AT_hook	AHDC1 KMT2A BOD1L1	7.26e-04	27	123	3	SM00384
Domain	AT_hook_DNA-bd_motif	AHDC1 KMT2A BOD1L1	7.26e-04	27	123	3	IPR017956
Domain	Plectin	DST MACF1	8.84e-04	7	123	2	PF00681
Domain	Plectin_repeat	DST MACF1	8.84e-04	7	123	2	IPR001101
Domain	PLEC	DST MACF1	8.84e-04	7	123	2	SM00250
Domain	CH	SYNE1 DST MACF1 VAV3	8.89e-04	65	123	4	SM00033
Domain	GAF	EFCAB5 PDE5A	1.17e-03	8	123	2	IPR003018
Domain	Vps4_C	KATNAL1 KATNA1	1.17e-03	8	123	2	IPR015415
Domain	Vps4_C	KATNAL1 KATNA1	1.17e-03	8	123	2	PF09336
Domain	GAF	EFCAB5 PDE5A	1.17e-03	8	123	2	SM00065
Domain	CH	SYNE1 DST MACF1 VAV3	1.17e-03	70	123	4	PF00307
Domain	-	SYNE1 DST MACF1 VAV3	1.24e-03	71	123	4	1.10.418.10
Domain	CH	SYNE1 DST MACF1 VAV3	1.37e-03	73	123	4	PS50021
Domain	A1pp	PARP14 MACROD2	1.50e-03	9	123	2	SM00506
Domain	-	EFCAB5 PDE5A	1.50e-03	9	123	2	3.30.450.40
Domain	Biotin_lipoyl	DBT PCCA	1.50e-03	9	123	2	PF00364
Domain	Macro	PARP14 MACROD2	1.50e-03	9	123	2	PF01661
Domain	GAF_dom-like	EFCAB5 PDE5A	1.50e-03	9	123	2	IPR029016
Domain	CH-domain	SYNE1 DST MACF1 VAV3	1.52e-03	75	123	4	IPR001715
Domain	SPAN-X	SPANXD SPANXC	1.87e-03	10	123	2	PF07458
Domain	BIOTINYL_LIPOYL	DBT PCCA	1.87e-03	10	123	2	PS50968
Domain	Macro_dom	PARP14 MACROD2	1.87e-03	10	123	2	IPR002589
Domain	SPAN-X_fam	SPANXD SPANXC	1.87e-03	10	123	2	IPR010007
Domain	MACRO	PARP14 MACROD2	1.87e-03	10	123	2	PS51154
Domain	Biotin_lipoyl	DBT PCCA	1.87e-03	10	123	2	IPR000089
Domain	ZF_CXXC	KMT2A KDM2A	2.28e-03	11	123	2	PS51058
Domain	Znf_CXXC	KMT2A KDM2A	2.28e-03	11	123	2	IPR002857
Domain	zf-CXXC	KMT2A KDM2A	2.28e-03	11	123	2	PF02008
Domain	Single_hybrid_motif	DBT PCCA	2.72e-03	12	123	2	IPR011053
Pathway	REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	2.09e-07	9	92	4	MM15509
Pathway	REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	3.46e-07	10	92	4	M27764
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	5.41e-07	11	92	4	MM15510
Pathway	REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	8.08e-07	12	92	4	M27765
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	2.28e-05	26	92	4	MM15502
Pathway	WP_CILIARY_LANDSCAPE	TFAP2D TFAP2E MCM3 LCN2 TFAP2A TFAP2C NEFM ARFGAP3	7.97e-05	215	92	8	M39734
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS	TFAP2D TFAP2E TFAP2A TFAP2C	1.06e-04	38	92	4	M27757
Pathway	REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS	TFAP2A TFAP2C	4.16e-04	5	92	2	M27767
Pubmed	Conditional deletion of activating protein 2alpha (AP-2alpha) in the developing retina demonstrates non-cell-autonomous roles for AP-2alpha in optic cup development.	TFAP2D TFAP2E TFAP2A TFAP2C MKI67	7.84e-10	13	128	5	17724084
Pubmed	Analysis of transcription factor AP-2 expression and function during mouse preimplantation development.	TFAP2D TFAP2E TFAP2A TFAP2C	8.73e-10	5	128	4	16672719
Pubmed	AP-2α and AP-2β regulate dorsal interneuron specification in the spinal cord.	TFAP2D TFAP2E TFAP2A TFAP2C	8.73e-10	5	128	4	27984181
Pubmed	Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb.	TFAP2D TFAP2E TFAP2A TFAP2C	6.07e-09	7	128	4	14572467
Pubmed	AP-2ε Expression in Developing Retina: Contributing to the Molecular Diversity of Amacrine Cells.	TFAP2D TFAP2E TFAP2A TFAP2C	6.07e-09	7	128	4	29467543
Pubmed	AP2gamma regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex.	TFAP2D TFAP2E TFAP2A TFAP2C MKI67	3.86e-08	26	128	5	19749747
Pubmed	Expression of the mouse Macf2 gene during inner ear development.	NEFM DST MACF1	4.87e-08	3	128	3	12399109
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	TRIO SYNE1 PCLO CNRIP1 GRIN2A NEFM SIPA1L1 MACF1 AKAP11 DCLK1	9.91e-08	281	128	10	28706196
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SYNE1 BIRC6 DST ALMS1 SIPA1L1 MACF1 AKAP11 KDM2A RPRD2	1.66e-07	225	128	9	12168954
Pubmed	Expression of Tfap2d, the gene encoding the transcription factor Ap-2 delta, during mouse embryogenesis.	TFAP2D TFAP2A TFAP2C	1.94e-07	4	128	3	12711551
Pubmed	HENA, heterogeneous network-based data set for Alzheimer's disease.	TRIO SYNE1 DST ALMS1 ZNF92 OLFM1 MACF1	3.27e-07	120	128	7	31413325
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	GPRASP1 DNAJC13 TRIO SYNE1 CNRIP1 MCM3 GRIN2A NEFM CCDC88C DST SIPA1L1 SVIL MACF1 PKN1 CABIN1 DCLK1	5.45e-07	963	128	16	28671696
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MAP1B POLR2B MCM3 TFAP2A NEFM ALMS1 AMOTL1 KMT2A KDM2A RPRD2 BOD1L1 PCCA	9.59e-07	549	128	12	38280479
Pubmed	Cardiac malformations, adrenal agenesis, neural crest defects and exencephaly in mice lacking Cited2, a new Tfap2 co-activator.	TFAP2A TFAP2C NEFM	9.66e-07	6	128	3	11694877
Pubmed	Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.	CADM3 MAP1B SIPA1L1 KMT2A AKAP11 KDM2A	1.07e-06	90	128	6	15033168
Pubmed	Genetic Screens Reveal FEN1 and APEX2 as BRCA2 Synthetic Lethal Targets.	POLE AHDC1 DCLRE1C DBF4 MKI67 KMT2A RPRD2	2.00e-06	157	128	7	30686591
Pubmed	Overlapping expression patterns and redundant roles for AP-2 transcription factors in the developing mammalian retina.	TFAP2A TFAP2C NEFM MKI67	2.09e-06	25	128	4	22411557
Pubmed	AP-2δ is a crucial transcriptional regulator of the posterior midbrain.	TFAP2D TFAP2E SLA TFAP2C	2.09e-06	25	128	4	21858141
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 DNAJC13 LRRN1 MAP1B TRIO KATNAL1 AHDC1 MACF1 KDM2A RPRD2 PKN1 BOD1L1 EIF2AK4 ANKRD12 DAAM1 TANGO2 MBD5 PCCA XPO7	2.30e-06	1489	128	19	28611215
Pubmed	Integrin receptors are required for cell survival and proliferation during development of the peripheral glial lineage.	TFAP2A TFAP2C NEFM	2.69e-06	8	128	3	11319856
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	NOL4 LCORL SMC6 TFAP2A FSIP2 DDX54 MKI67 KMT2A KDM2A BOD1L1 CABIN1 SENP7	2.75e-06	608	128	12	36089195
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	MAP1B TRIO FSIP2 CCDC88C DST ALMS1 SLF2 SIPA1L1 SVIL KMT2A MACF1 AKAP11 BOD1L1 DCLK1	3.75e-06	861	128	14	36931259
Pubmed	MLL1 is essential for retinal neurogenesis and horizontal inner neuron integrity.	TFAP2A NEFM MKI67 KMT2A	3.87e-06	29	128	4	30093671
Pubmed	Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module.	MCM3 E2F2 SLFN12L DST MKI67 MACF1 TAF10	4.42e-06	177	128	7	22560297
Pubmed	Placing the HIRA histone chaperone complex in the chromatin landscape.	BDP1 TFAP2A TFAP2C CABIN1	5.10e-06	31	128	4	23602572
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SPATA2 ALMS1 SIPA1L1 SVIL MKI67 RPRD2 ANKRD12	5.70e-06	184	128	7	32908313
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	DNAJC13 SMC6 MUC16 MCM3 SPATA2 BIRC6 DST ARFGAP3 AMOTL1 MKI67 PKN1 PCCA XPO7	6.27e-06	777	128	13	35844135
Pubmed	Activating enhancer binding protein 2 epsilon (AP-2ε)-deficient mice exhibit increased matrix metalloproteinase 13 expression and progressive osteoarthritis development.	TFAP2E TFAP2A TFAP2C	1.05e-05	12	128	3	25964075
Pubmed	Inhibition of RIF1 by SCAI Allows BRCA1-Mediated Repair.	POLR2B REV3L AHDC1	1.05e-05	12	128	3	28700933
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	POLR2B SMC6 BTLA SLFN12L KLHL5 MPZL3 SIPA1L1 MACF1 BOD1L1 EIF2AK4 ANKRD12 TANGO2 ANKRD40 DCLK1 TGS1	1.15e-05	1084	128	15	11544199
Pubmed	Immunohistochemical expression patterns of AP2alpha and AP2gamma in the developing fetal human breast.	TFAP2A TFAP2C	1.34e-05	2	128	2	18042070
Pubmed	Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases.	KMT2A MLLT3	1.34e-05	2	128	2	20395514
Pubmed	Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.	KMT2A MLLT3	1.34e-05	2	128	2	32768438
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	1.34e-05	2	128	2	11002341
Pubmed	Mouse mutants in schizophrenia risk genes GRIN2A and AKAP11 show EEG abnormalities in common with schizophrenia patients.	GRIN2A AKAP11	1.34e-05	2	128	2	36914641
Pubmed	Impact of MLL::AF9 Gene Rearrangement on Survival of Acute Myeloid Leukaemia Patients: An Insight into Pakistani Population.	KMT2A MLLT3	1.34e-05	2	128	2	38576284
Pubmed	Type Igamma661 phosphatidylinositol phosphate kinase directly interacts with AP2 and regulates endocytosis.	PIP5K1C TFAP2A	1.34e-05	2	128	2	16707488
Pubmed	Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia.	KMT2A MLLT3	1.34e-05	2	128	2	21959947
Pubmed	Microtubule stability, Golgi organization, and transport flux require dystonin-a2-MAP1B interaction.	MAP1B DST	1.34e-05	2	128	2	22412020
Pubmed	Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties.	TFAP2D TFAP2A	1.34e-05	2	128	2	11522791
Pubmed	Activator protein-2 impairs the invasion of a human extravillous trophoblast cell line.	TFAP2A TFAP2C	1.34e-05	2	128	2	19443578
Pubmed	AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis.	TFAP2A TFAP2C	1.34e-05	2	128	2	8808408
Pubmed	The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.	TFAP2A TFAP2C	1.34e-05	2	128	2	30824562
Pubmed	Exencephaly in a subset of animals heterozygous for AP-2alpha mutation.	TFAP2A NEFM	1.34e-05	2	128	2	11967920
Pubmed	AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.	TFAP2A TFAP2C	1.34e-05	2	128	2	18443366
Pubmed	Prognostic significance of expression of CD133 and Ki-67 in gastric cancer.	PROM1 MKI67	1.34e-05	2	128	2	25339008
Pubmed	Functional genomics of AP-2α and AP-2γ in cancers: in silico study.	TFAP2A TFAP2C	1.34e-05	2	128	2	33213447
Pubmed	Truncation of the Mll gene in exon 5 by gene targeting leads to early preimplantation lethality of homozygous embryos.	NEFM KMT2A	1.34e-05	2	128	2	11536426
Pubmed	Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.	TFAP2A TFAP2C	1.34e-05	2	128	2	20459791
Pubmed	MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.	KMT2A MLLT3	1.34e-05	2	128	2	27344946
Pubmed	Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.	MCM3 MKI67	1.34e-05	2	128	2	31980982
Pubmed	Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.	MCM3 MKI67	1.34e-05	2	128	2	19818763
Pubmed	In vitro study on the effect of doxorubicin on the proliferation markers MCM3 and Ki-67.	MCM3 MKI67	1.34e-05	2	128	2	24344040
Pubmed	KATNAL1 is a more active and stable isoform of katanin, and is expressed dominantly in neurons.	KATNAL1 KATNA1	1.34e-05	2	128	2	30448058
Pubmed	MLL-AF9 regulates transcriptional initiation in mixed lineage leukemic cells.	KMT2A MLLT3	1.34e-05	2	128	2	39002676
Pubmed	Exosomes from metastatic colon cancer cells drive the proliferation and migration of primary colon cancer through increased expression of cancer stem cell markers CD133 and DCLK1.	PROM1 DCLK1	1.34e-05	2	128	2	37487255
Pubmed	MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.	KMT2A MLLT3	1.34e-05	2	128	2	23178754
Pubmed	MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors.	MCM3 MKI67	1.34e-05	2	128	2	33433405
Pubmed	The katanin A-subunits KATNA1 and KATNAL1 act co-operatively in mammalian meiosis and spermiogenesis to achieve male fertility.	KATNAL1 KATNA1	1.34e-05	2	128	2	37882691
Pubmed	Inter-chromosomal recombination of Mll and Af9 genes mediated by cre-loxP in mouse development.	KMT2A MLLT3	1.34e-05	2	128	2	11265751
Pubmed	Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma.	PROM1 MKI67	1.34e-05	2	128	2	20487522
Pubmed	A family of AP-2 proteins down-regulate manganese superoxide dismutase expression.	TFAP2A TFAP2C	1.34e-05	2	128	2	11278550
Pubmed	An insertional mutagenesis screen identifies genes that cooperate with Mll-AF9 in a murine leukemogenesis model.	KMT2A MLLT3	1.34e-05	2	128	2	22427200
Pubmed	Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.	KMT2A MLLT3	1.34e-05	2	128	2	30387535
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CADM3 GPRASP1 MAP1B TRIO PCLO GRIN2A DBT BIRC6 ARFGAP3 SIPA1L1 OLFM1 MACF1 DAAM1 PCCA DCLK1	2.04e-05	1139	128	15	36417873
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 TRIO SYNE1 CNRIP1 REV3L NEFM DST SLF2 ZNF92 SIPA1L1 OLFM1 MACF1 MLLT3 CABIN1 DCLK1 KLHL4	2.10e-05	1285	128	16	35914814
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SYNE1 SPATA2 PIP5K1C SIPA1L1 MACF1 BOD1L1 ANKRD12 SENP7 XPO7	2.11e-05	407	128	9	12693553
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	TRIO SYNE1 NEFM DST OLFM1 MACF1	2.13e-05	151	128	6	17043677
Pubmed	The cell proliferation antigen Ki-67 organises heterochromatin.	MAP1B MCM3 PARP14 DST SIPA1L1 DDX54 MKI67 TAF10 DCLK1	2.23e-05	410	128	9	26949251
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	MAP1B PCLO GRIN2A NEFM SIPA1L1 MACF1 DCLK1	2.49e-05	231	128	7	16452087
Pubmed	IRF6 and AP2A Interaction Regulates Epidermal Development.	TFAP2A TFAP2C MKI67	2.63e-05	16	128	3	29913133
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	DNAJC13 MAP1B SPATA2 ALMS1 ARFGAP3 AMOTL1 PKN1 PCCA	2.70e-05	322	128	8	39098523
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EFCAB5 SYNE1 OVCH1 KLHL5 DST DDX54 MACF1	2.70e-05	234	128	7	36243803
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TRIO PARP14 AHDC1 DST AMOTL1 SVIL MACF1 KDM2A	3.36e-05	332	128	8	37433992
Pubmed	Prediction of the coding sequences of unidentified human genes. XI. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYNE1 SPATA2 DST MACF1 XPO7	3.73e-05	101	128	5	9872452
Pubmed	Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization.	MAP1B NEFM	4.02e-05	3	128	2	11581286
Pubmed	Sumoylation pathway is required to maintain the basal breast cancer subtype.	TFAP2A TFAP2C	4.02e-05	3	128	2	24835590
Pubmed	Regulation of Hoxa2 in cranial neural crest cells involves members of the AP-2 family.	TFAP2A TFAP2C	4.02e-05	3	128	2	10068641
Pubmed	Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.	MUC16 MKI67	4.02e-05	3	128	2	27163153
Pubmed	The mouse Mcmd gene for DNA replication protein P1MCM3 maps to bands A3-A5 on chromosome 1 by fluorescence in situ hybridization.	MCM3 DST	4.02e-05	3	128	2	8838817
Pubmed	AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.	TFAP2A TFAP2C	4.02e-05	3	128	2	16636674
Pubmed	Generation and characterization of a novel neural crest marker allele, Inka1-LacZ, reveals a role for Inka1 in mouse neural tube closure.	TFAP2A NEFM	4.02e-05	3	128	2	20175189
Pubmed	CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis.	KMT2A MLLT3	4.02e-05	3	128	2	32549410
Pubmed	FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis.	KMT2A MLLT3	4.02e-05	3	128	2	30953031
Pubmed	Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.	KMT2A MLLT3	4.02e-05	3	128	2	18538732
Pubmed	High BRE expression predicts favorable outcome in adult acute myeloid leukemia, in particular among MLL-AF9-positive patients.	KMT2A MLLT3	4.02e-05	3	128	2	21937695
Pubmed	Expression of AP-2α, AP-2γ and ESDN in primary melanomas: correlation with histopathological features and potential prognostic value.	TFAP2A TFAP2C	4.02e-05	3	128	2	23036739
Pubmed	MAP1B and clathrin are novel interacting partners of the giant cyto-linker dystonin.	MAP1B DST	4.02e-05	3	128	2	21936565
Pubmed	The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.	KMT2A MLLT3	4.02e-05	3	128	2	36358022
Pubmed	Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma.	TFAP2A TFAP2C	4.02e-05	3	128	2	32462520
Pubmed	The cancer-testis antigens SPANX-A/C/D and CTAG2 promote breast cancer invasion.	SPANXD SPANXC	4.02e-05	3	128	2	26895102
Pubmed	Down-regulation of MLL-AF9, MLL and MYC expression is not obligatory for monocyte-macrophage maturation in AML-M5 cell lines carrying t(9;11)(p22;q23).	KMT2A MLLT3	4.02e-05	3	128	2	16328057
Pubmed	Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death.	KMT2A MLLT3	4.02e-05	3	128	2	23624644
Pubmed	Splicing variants of NOL4 differentially regulate the transcription activity of Mlr1 and Mlr2 in cultured cells.	NOL4 LCORL	4.02e-05	3	128	2	25366156
Pubmed	The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.	TRIO VAV3	4.02e-05	3	128	2	19008376
Pubmed	Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor.	TFAP2A TFAP2C	4.02e-05	3	128	2	15548692
Pubmed	Transcription of cholesterol side-chain cleavage cytochrome P450 in the placenta: activating protein-2 assumes the role of steroidogenic factor-1 by binding to an overlapping promoter element.	TFAP2A TFAP2C	4.02e-05	3	128	2	12145340
Pubmed	A novel alternative spliced variant of the transcription factor AP2alpha is expressed in the murine ocular lens.	TFAP2A TFAP2C	4.02e-05	3	128	2	9758708
Pubmed	Developmental regulation and overexpression of the transcription factor AP-2, a potential regulator of the timing of Schwann cell generation.	TFAP2A TFAP2C	4.02e-05	3	128	2	11553286
Pubmed	AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells.	TFAP2A TFAP2C	4.02e-05	3	128	2	16867219
Interaction	DISC1 interactions	TRIO SYNE1 CDKL3 KATNAL1 NEFM KIF9 DST ALMS1 SVIL OLFM1 MACF1 PKN1 MXD1	2.26e-06	429	123	13	int:DISC1
Coexpression	BROWNE_HCMV_INFECTION_20HR_DN	TRIO SYNE1 REV3L DST SIPA1L1 SVIL MACF1	6.01e-07	102	125	7	M5601
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN	CADM3 LRRN1 SYNE1 FSIP2 CCDC88C SIPA1L1 CABIN1	6.86e-07	104	125	7	M8938
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	BDP1 CADM3 GPRASP1 NOL4 MAP1B PCLO BIVM REV3L AHDC1 ANKRD36B FSIP2 SLC25A12 OLFM1 MLLT3 BOD1L1 VAV3 ANKRD12 DAAM1 DCLK1	1.27e-06	1106	125	19	M39071
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MOK DNAJC13 MAP1B TRIO POLR2B REV3L AHDC1 RYK DST SLC25A12 DBF4 SIPA1L1 MACF1 AKAP11 DAAM1 PCCA	3.28e-06	856	125	16	M4500
Coexpression	LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2	SYNE1 DST SVIL MACROD2 MACF1 MBD5	3.59e-06	86	125	6	M39248
Coexpression	GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN	TRIO POLE E2F2 SLA DBF4 MKI67 RPRD2 PCCA	5.48e-06	200	125	8	M8257
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	PCSK5 BDP1 DNAJC13 ICE2 SMC6 REV3L DCLRE1C DBF4 MKI67 OLFM1 AKAP11 DAAM1 PCCA	1.58e-05	656	125	13	M18979
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MAP1B TRIO LCORL SYNE1 CNRIP1 KATNAL1 KLHL5 DST ALMS1 SVIL MLLT3 ANKRD12 TANGO2 CABIN1 DCLK1 MXD1 TGS1	1.96e-05	1102	125	17	M2369
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL	LRRN1 SLA TFAP2C CCDC88C KLHL5 SIPA1L1 SVIL MACROD2 TAF10 PCCA DCLK1 KLHL4	2.60e-05	589	125	12	M45662
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	BDP1 GPRASP1 NOL4 MAP1B PCLO REV3L AHDC1 ANKRD36B OLFM1 VAV3 ANKRD12 DAAM1 DCLK1	3.24e-05	703	125	13	M39070
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	FREM1 DST SVIL MACROD2 VAV3 MBD5 PCCA	6.48e-05	208	125	7	M39233
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP	DNAJC13 TRIO SLC39A9 ELP3 DCLRE1C MKI67 MACF1 ANKRD12 ANKRD40	8.62e-05	378	125	9	M41174
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	MAP1B TRIO SYNE1 CNRIP1 KATNAL1 KLHL5 DST ALMS1 SVIL MLLT3 ANKRD12 TANGO2 CABIN1 DCLK1 MXD1 TGS1	9.07e-05	1124	125	16	MM1070
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL	UBD MUC16 LCN2 TFAP2A PROM1 KLHL5 MPZL3	1.09e-04	226	125	7	M45709
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	LRRN1 MAP1B TRIO PCLO POLR2B PROM1 KLHL5 DCLRE1C SIPA1L1 MKI67 MACF1 KDM2A RPRD2 BOD1L1 VAV3 EIF2AK4 PCCA	3.27e-08	595	118	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	MOK PCSK5 BDP1 ICE2 PCLO CDKL3 REV3L TFAP2A PROM1 KLHL5 MKI67 MACF1 PDE5A AKAP11 TTLL1 DAAM1 MBD5 ANKRD40 MXD1 SENP7	4.78e-07	985	118	20	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	MAP1B PCLO CCDC88C PROM1 OLFM1 MACF1 DAAM1	1.25e-06	98	118	7	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	EFCAB5 SLCO2B1 ICE2 POLE POLR2B SMC6 REV3L TFAP2A FREM1 NEFM PROM1 ALMS1 DBF4 MKI67 ZNF506 MLLT3 BOD1L1 ANKRD12 MBD5 PCCA SENP7 TGS1	1.35e-06	1252	118	22	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5	MOK PCLO PROM1 PDE5A AKAP11 TTLL1 DAAM1 ANKRD40 SENP7	4.08e-06	221	118	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	MOK BDP1 NOL4 LRRN1 MAP1B SLCO2B1 ICE2 POLE SMC6 REV3L TFAP2A TFAP2C NEFM CCDC88C PROM1 ALMS1 DBF4 MKI67 ZNF506 MACF1 BOD1L1 MBD5 TGS1	4.69e-06	1459	118	23	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	MOK EFCAB5 CADM3 NOL4 LRRN1 MAP1B BIVM SMC6 E2F2 REV3L NEFM CCDC88C PROM1 ALMS1 MKI67 OLFM1 MLLT3 BOD1L1 TTLL1 DCLK1 SENP7 TGS1	5.84e-06	1370	118	22	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	MOK CADM3 LRRN1 MAP1B SLCO2B1 ICE2 SMC6 CDKL3 KATNAL1 CCDC88C PROM1 ALMS1 DBF4 MKI67 ZNF506 MACF1 BOD1L1 PCCA TGS1	5.94e-06	1060	118	19	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	BDP1 LRRN1 MAP1B ICE2 PCLO SMC6 REV3L NEFM CCDC88C PROM1 KLHL5 ALMS1 DBF4 MKI67 MLLT3 BOD1L1 DAAM1 TGS1	8.74e-06	989	118	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	BDP1 ICE2 SMC6 REV3L KLHL5 ALMS1 MKI67 MLLT3 BOD1L1 TGS1	9.49e-06	311	118	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 ICE2 ALMS1 SLF2 MKI67 MACF1 BOD1L1 TGS1	9.59e-06	186	118	8	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	MOK CADM3 NOL4 LRRN1 MAP1B SLCO2B1 ICE2 SMC6 CDKL3 KATNAL1 NEFM CCDC88C PROM1 ALMS1 MPZL3 DBF4 MKI67 ZNF506 MACF1 BOD1L1 PCCA TGS1	9.63e-06	1414	118	22	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	MOK BDP1 LRRN1 MAP1B PCLO SMC6 NEFM PROM1 KLHL5 ALMS1 DBF4 MKI67 MLLT3 BOD1L1 ANKRD40 TGS1	1.46e-05	831	118	16	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	BDP1 TRIO ICE2 POLR2B KLHL5 DCLRE1C SLF2 DBF4 MKI67 MACF1 VAV3 EIF2AK4 PCCA	1.55e-05	564	118	13	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	BDP1 ICE2 SYNE1 SMC6 REV3L KLHL5 SLF2 MKI67 MACF1 BOD1L1 EIF2AK4	2.96e-05	432	118	11	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	LRRN1 MAP1B PCLO NEFM CCDC88C PROM1 DBF4 DAAM1	4.55e-05	231	118	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	MOK LRRN1 MAP1B PCLO SMC6 NEFM PROM1 DST ALMS1 DBF4 MLLT3 ANKRD12 TGS1	7.15e-05	654	118	13	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	BDP1 TFAP2D ICE2 SLC25A12 ALMS1 SLF2 MKI67 MACF1 BOD1L1 DAAM1 TGS1	9.51e-05	492	118	11	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	PCSK5 BDP1 ICE2 PCLO REV3L TFAP2A PROM1 KLHL5 MKI67 MACF1 SENP7	9.51e-05	492	118	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	BDP1 ICE2 PCLO PROM1 KLHL5 MKI67 MACF1	1.00e-04	192	118	7	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	LRRN1 MAP1B POLE PCLO CCDC88C PROM1 DST ALMS1	1.01e-04	259	118	8	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	LRRN1 MAP1B PCLO NEFM CCDC88C PROM1	1.28e-04	139	118	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	DNAJC13 LRRN1 MAP1B LCORL MIER3 MCM3 ELP3 BIRC6 TFAP2C NEFM DCLK1 SENP7 TGS1 KLHL4	1.74e-04	815	118	14	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	MOK BDP1 LRRN1 ICE2 POLE SMC6 REV3L TFAP2C CCDC88C PROM1 ALMS1 DBF4 MKI67 ZNF506 MACF1 BOD1L1 MBD5 TGS1	1.96e-04	1257	118	18	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BDP1 LRRN1 ICE2 POLR2B SMC6 KLHL5 DCLRE1C SLF2 MKI67 MACF1 BOD1L1 EIF2AK4	2.01e-04	629	118	12	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000	TFAP2A TFAP2C FREM1 MLLT3 DCLK1	2.19e-04	98	118	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k3
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	PCSK5 LRRN1 ICE2 CNRIP1 KATNAL1 FREM1 NEFM DST SVIL MACROD2 MLLT3 VAV3 ANKRD12 TANGO2 MBD5 DCLK1 SENP7	2.44e-04	1166	118	17	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	LRRN1 MAP1B PCLO NEFM CCDC88C PROM1 ALMS1 TGS1	2.64e-04	298	118	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 LRRN1 MAP1B NEFM PROM1 DBF4 TGS1	3.20e-04	232	118	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	ICE2 ALMS1 CATSPER2 AKAP11 ANKRD12	3.74e-04	110	118	5	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_200	MAP1B TRIO TFAP2A TFAP2C NEFM DST	3.79e-04	170	118	6	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_200
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	DNAJC13 LRRN1 LCORL ICE2 MIER3 SMC6 MCM3 BIRC6 ALMS1 MACROD2 ANKRD12 SENP7 KLHL4	3.82e-04	776	118	13	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000	BDP1 ICE2 SYNE1 PCLO SMC6 REV3L KLHL5 SLF2 MPZL3 DDX54 MKI67 MACF1 BOD1L1 EIF2AK4 SENP7	3.86e-04	989	118	15	Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000	PCSK5 LRRN1 TRIO NEFM SVIL MLLT3 PDE5A TTLL1 VAV3 ANKRD12 DCLK1 SENP7 KLHL4	4.57e-04	791	118	13	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500	BDP1 LRRN1 MAP1B PCLO SMC6 NEFM CCDC88C PROM1 ALMS1 TGS1	4.68e-04	498	118	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	MOK LRRN1 MAP1B PCLO NEFM PROM1 ALMS1 DBF4	5.00e-04	328	118	8	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3	LRRN1 PCLO CCDC88C PROM1 DST	5.17e-04	118	118	5	Facebase_RNAseq_e8.5_Floor Plate_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	BDP1 SMC6 NEFM PROM1 ALMS1 TGS1	7.20e-04	192	118	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000	DNAJC13 LCORL MIER3 BIRC6 ANKRD12	7.21e-04	127	118	5	gudmap_developingGonad_e16.5_epididymis_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#2	PCLO CATSPER2 PDE5A AKAP11 TTLL1 DAAM1 DCLK1 MXD1 SENP7	7.55e-04	437	118	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K2
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	LRRN1 LCORL MIER3 TFAP2A TFAP2C NEFM DST AMOTL1 MACROD2 MLLT3 PDE5A RPRD2 DCLK1	7.66e-04	836	118	13	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 MAP1B POLE PCLO SMC6 BIRC6 PROM1 ALMS1 DBF4 MLLT3	7.78e-04	532	118	10	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5	CADM3 LRRN1 PCLO E2F2 CCDC88C PROM1 DST SLC25A12 MLLT3 PKN1 ANKRD12 SENP7	7.80e-04	732	118	12	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3	LRRN1 SLC25A12 ALMS1 MACF1 DAAM1 SENP7 TGS1	8.07e-04	271	118	7	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_200	TFAP2A TFAP2C DST	8.08e-04	33	118	3	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_200
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA C11orf96 OLFM1 ANKRD12 DAAM1	5.69e-09	199	126	9	77b4aa00f14b86ef5db0490be98787e063979541
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	BDP1 MAP1B PCLO CNRIP1 SLA NEFM MACROD2 DAAM1 DCLK1	5.95e-09	200	126	9	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	BDP1 MAP1B PCLO CNRIP1 SLA NEFM MACROD2 DAAM1 DCLK1	5.95e-09	200	126	9	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO REV3L DST KMT2A MACF1 PDE5A BOD1L1	8.75e-08	195	126	8	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SYNE1 PCLO GRIN2A ANKRD36B MACROD2 OLFM1 DCLK1	9.10e-08	196	126	8	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	BDP1 CADM3 MAP1B PCLO CNRIP1 MACROD2 DAAM1 DCLK1	1.02e-07	199	126	8	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST SVIL PDE5A ATP1A4	1.02e-07	199	126	8	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	BDP1 CADM3 MAP1B PCLO CNRIP1 MACROD2 DAAM1 DCLK1	1.02e-07	199	126	8	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	MAP1B PCLO SMC6 REV3L KLHL5 DST BOD1L1 ANKRD12	1.02e-07	199	126	8	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 PCLO NEFM C11orf96 OLFM1 DAAM1 DCLK1	1.02e-07	199	126	8	5de2a32bc2e9c752eb19a013b1807949153728fc
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA NEFM C11orf96 OLFM1	1.02e-07	199	126	8	1029f3458b7fda464aa0e7ef06e081e2618c1388
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA NEFM C11orf96 OLFM1	1.02e-07	199	126	8	8a04398653a1794921d73a6a950c1fb6fdf68c85
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal\|2m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO CNRIP1 NEFM OLFM1 ANKRD12	1.06e-07	200	126	8	60b86c4a4e247b2673d31b085b440a6e574393bb
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 PARP14 BIRC6 KMT2A MACF1 KDM2A BOD1L1 ANKRD12	1.06e-07	200	126	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST SVIL PDE5A ATP1A4	1.06e-07	200	126	8	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST SVIL PDE5A ATP1A4	1.06e-07	200	126	8	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST SVIL PDE5A ATP1A4	1.06e-07	200	126	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8\|Lung / Manually curated celltypes from each tissue	ANKRD36B CCDC88C SLFN12L KMT2A MACF1 MLLT3 ANKRD12	2.52e-07	151	126	7	999c11d19b61d6b130ad5e623afa83cbdfe13cdd
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FREM1 PROM1 SLFN12L DST MACF1 MBD5 PCCA	1.41e-06	195	126	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO REV3L DST KMT2A MACF1 BOD1L1	1.41e-06	195	126	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Neuron\|World / Primary Cells by Cluster	MAP1B PCLO SLA NEFM MLLT3 ANKRD12 DAAM1	1.61e-06	199	126	7	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	MAP1B PCLO SLA NEFM MLLT3 ANKRD12 DAAM1	1.61e-06	199	126	7	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 SVIL PDE5A ATP1A4	1.67e-06	200	126	7	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	BDP1 MAP1B SYNE1 PCLO GRIN2A ANKRD36B DCLK1	1.67e-06	200	126	7	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron\|3m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA OLFM1 MLLT3	1.67e-06	200	126	7	c248233b004f8ef0bab3c65ecfe295887966f2ee
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal\|3m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA OLFM1 MLLT3	1.67e-06	200	126	7	af99d90070e2933fd2e9512590c6cf3bd6e15539
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST SVIL PDE5A	1.67e-06	200	126	7	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Cortical_neuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	TFAP2D MAP1B CNRIP1 NEFM OLFM1 DAAM1 DCLK1	1.67e-06	200	126	7	0185b4ad6b512d24efff806460ee1b57e42096e9
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	PARP14 KMT2A MACF1 KDM2A BOD1L1 ANKRD12 TAF10	1.67e-06	200	126	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal\|6m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA NEFM OLFM1	1.67e-06	200	126	7	cedbc47b1defb5973cf7ab6baaa2d6f2fd481f88
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Cortical_neuron\|6m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO SLA NEFM OLFM1	1.67e-06	200	126	7	6f7ff0533339fcc9d316f2c77334a79c1409ec4f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Cortical_neuron\|2m / Sample Type, Dataset, Time_group, and Cell type.	CADM3 NOL4 MAP1B PCLO CNRIP1 NEFM OLFM1	1.67e-06	200	126	7	db2dbd31dd02c0d1c1070ed5548ce949227e4775
ToppCell	5'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CNRIP1 FREM1 CATSPER2 PDE5A ATP1A4 MXD1	7.87e-06	166	126	6	a42268a02a89fc97272e45c4cbe21acf04b7428c
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 E2F2 LCN2 MKI67 OLFM1 XPO7	8.15e-06	167	126	6	1bd27ffe381d26731b6d4cc5f29b27f1bac4473b
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SYNE1 E2F2 LCN2 MKI67 OLFM1 XPO7	8.43e-06	168	126	6	faaba5ac01c2ebe380f56559374a121979a85a13
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 ABCA12 MIER3 PROM1 DST VAV3	9.96e-06	173	126	6	e1378201b15ffb98e196ac39fe3ee4b4078953bd
ToppCell	facs-Large_Intestine-Proximal-3m\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PCSK5 ABCA12 MIER3 PROM1 DST VAV3	9.96e-06	173	126	6	99532bb768ee35fed939a377acb5215d3f8904bd
ToppCell	Adult-Epithelial-club_cell-D175\|Adult / Lineage, Cell type, age group and donor	NOL4 LRRN1 LCN2 PROM1 MACROD2 C4BPA	1.13e-05	177	126	6	d652b7d84fe6aa38319d8d5adc72c70441bd0088
ToppCell	10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	DNAJC13 LRRN1 SYNE1 POLE LCN2 SLA	1.33e-05	182	126	6	52eac2f892ea7f26731e0b21c578fd2665a1657a
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PCSK5 MAP1B LCORL RYK C11orf96 PDE5A	1.46e-05	185	126	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO GRIN2A TFAP2A NEFM OLFM1	1.55e-05	187	126	6	e04a84989d624378141042768383b9c846901f2d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO GRIN2A TFAP2A NEFM OLFM1	1.55e-05	187	126	6	24cc03c748e15f7ef0e6509ca5a6ca583fb9c573
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B PCLO GRIN2A TFAP2A NEFM OLFM1	1.55e-05	187	126	6	2f153b203fe79f206319603cf94d3a03ab49a05d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PCSK5 LRRN1 SYNE1 FREM1 PROM1 PDE5A	1.60e-05	188	126	6	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	CNRIP1 E2F2 MKI67 OSBP2 TANGO2 XPO7	1.70e-05	190	126	6	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAP1B KLHL5 DST AMOTL1 MACF1 PDE5A	1.70e-05	190	126	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NOL4 LRRN1 MAP1B PCLO DST PDE5A	1.75e-05	191	126	6	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRN1 POLE E2F2 SLFN12L MACF1 ERICH6	1.80e-05	192	126	6	930319cbd82b9e54864147ffcdc8bd0ea7b937be
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLCO2B1 PCLO PKN1 VAV3 DAAM1 KLHL4	1.80e-05	192	126	6	b016e229300c183e14c0e2bba494bf49c7899112
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LRRN1 POLE E2F2 SLFN12L MACF1 ERICH6	1.80e-05	192	126	6	c7bcebcb88a25b2c97d798120efa9d5958e7f798
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	SLCO2B1 PCLO PKN1 VAV3 DAAM1 KLHL4	1.80e-05	192	126	6	ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO ARFGAP3 C11orf96 SVIL MACF1 DCLK1	1.80e-05	192	126	6	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TRIO SIPA1L1 SVIL MACF1 MBD5 PCCA	1.80e-05	192	126	6	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAP1B SYNE1 C11orf96 SVIL PDE5A DCLK1	1.85e-05	193	126	6	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM3 NOL4 MAP1B PCLO OLFM1 DCLK1	1.85e-05	193	126	6	a189d46c39067b717509cd144e0225cc93d7731d
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MAP1B SYNE1 C11orf96 SVIL PDE5A DCLK1	1.85e-05	193	126	6	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	COPD-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	MAP1B SLCO2B1 DST OSBP2 VAV3 KLHL4	1.96e-05	195	126	6	e91ce548ae7224661ee5d2f2639794a5f69798ee
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 SMC6 PARP14 SIPA1L1 MACROD2 BOD1L1	1.96e-05	195	126	6	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 SMC6 PARP14 SIPA1L1 MACROD2 BOD1L1	1.96e-05	195	126	6	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	Control-Endothelial-Lymphatic\|Endothelial / Disease state, Lineage and Cell class	MAP1B SLCO2B1 DST OSBP2 VAV3 KLHL4	2.02e-05	196	126	6	e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SYNE1 SLFN12L KMT2A MACF1 MLLT3 ANKRD12	2.08e-05	197	126	6	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SYNE1 PCLO GRIN2A OLFM1 DCLK1	2.14e-05	198	126	6	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SYNE1 SLA CCDC88C SLFN12L KMT2A MACF1	2.14e-05	198	126	6	1ca6cd8e75891fdfaddbb4a7342eec9ca4d11e5d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SYNE1 PCLO GRIN2A OLFM1 DCLK1	2.14e-05	198	126	6	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SYNE1 PCLO GRIN2A OLFM1 DCLK1	2.14e-05	198	126	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	UBD LCN2 TFAP2A TFAP2C PROM1 MACROD2	2.14e-05	198	126	6	5d57acbe0d245f8bd217eeea07af060092898fbd
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	MAP1B PCLO SLA NEFM C11orf96 MLLT3	2.14e-05	198	126	6	076c862f2a723f0361749377561cae902068b1a0
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1B SYNE1 GRIN2A C11orf96 PDE5A KLHL4	2.14e-05	198	126	6	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B PCLO GRIN2A ANKRD36B OLFM1 DCLK1	2.14e-05	198	126	6	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 SYNE1 PARP14 SLFN12L MACF1 ANKRD12	2.20e-05	199	126	6	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM3 MAP1B TFAP2A NEFM DST OLFM1	2.20e-05	199	126	6	86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	SMC6 REV3L KLHL5 BOD1L1 ANKRD12 MXD1	2.20e-05	199	126	6	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM3 MAP1B PCLO TFAP2A DST OLFM1	2.20e-05	199	126	6	47466253069d4b1b8f13ce3210f434e60753b38a
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TRIO BIRC6 MACROD2 MLLT3 MBD5 PCCA	2.20e-05	199	126	6	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SYNE1 REV3L FREM1 DST OLFM1 MACF1	2.20e-05	199	126	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	IGHV2-26 SYNE1 PARP14 ANKRD36B SLFN12L ANKRD12	2.20e-05	199	126	6	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal\|GW26 / Sample Type, Dataset, Time_group, and Cell type.	NOL4 MAP1B SLA MLLT3 ANKRD12 DAAM1	2.20e-05	199	126	6	a255484ba77bd2741a541da278efc8cf4abbe570
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B POLE MCM3 DBF4 MKI67 OLFM1	2.20e-05	199	126	6	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	MAP1B PCLO SLA NEFM MLLT3 DAAM1	2.20e-05	199	126	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	TRIO SLCO2B1 BIRC6 DST KMT2A MACF1	2.26e-05	200	126	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 PDE5A ATP1A4	2.26e-05	200	126	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PCSK5 SYNE1 PROM1 SVIL PDE5A ATP1A4	2.26e-05	200	126	6	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 PDE5A ATP1A4	2.26e-05	200	126	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	NOL4 MAP1B PCLO SLA OLFM1 MLLT3	2.26e-05	200	126	6	e4f0bb57be1112869c7068d0a789c2b802a442dd
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 PDE5A ATP1A4	2.26e-05	200	126	6	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PCSK5 MAP1B SYNE1 PROM1 DST PDE5A	2.26e-05	200	126	6	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMC6 BTLA PARP14 SIPA1L1 MACROD2 VAV3	2.26e-05	200	126	6	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCSK5 CADM3 MAP1B CNRIP1 C11orf96 DCLK1	2.26e-05	200	126	6	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	BDP1 MAP1B PCLO CNRIP1 SLA NEFM	2.26e-05	200	126	6	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	BDP1 MAP1B PCLO CNRIP1 SLA NEFM	2.26e-05	200	126	6	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIER3 LCN2 PCTP CCDC88C MXD1	3.84e-05	133	126	5	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIER3 LCN2 PCTP CCDC88C MXD1	3.84e-05	133	126	5	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MIER3 MCM3 PDE5A OSBP2 TANGO2	5.79e-05	145	126	5	90ca38c02325c5c637c32efdef634b54cc3cd105
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb\|Cerebellum / BrainAtlas - Mouse McCarroll V32	EFCAB5 SLA TFAP2A VAV3 ANKRD12	6.59e-05	149	126	5	6e9ca280a599d96f8956ef26f2a46b9484de5488
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCN2 MPZL3 SVIL ZFYVE26 MXD1	6.80e-05	150	126	5	6e806a028c0519489151c181d9907e05289e27e0
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	IGHV2-26 SYNE1 ANKRD36B SLFN12L MACF1	8.19e-05	156	126	5	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POLE MKI67 OLFM1 AKAP11 XPO7	8.19e-05	156	126	5	8349604bd801e20d33770f7d8243598c3756302b
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PCLO LCN2 C11orf96 MACROD2 C4BPA	9.50e-05	161	126	5	78cb72c462167021195917a06052bcdc367ad890
ToppCell	356C-Epithelial_cells-Epithelial-C_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PCLO LCN2 C11orf96 MACROD2 C4BPA	9.50e-05	161	126	5	06e7becfd11d6ef1a45a9cfdfcb40b812600038e
ToppCell	droplet-Liver-Npc-18m-Epithelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LCN2 PROM1 MPZL3 MACROD2	9.96e-05	85	126	4	6496fd03eaf5ffb8264bbdd51d419acdd89f260c
Drug	HMP-P	TFAP2D TFAP2E TFAP2A TFAP2C C4BPA	1.77e-08	16	123	5	CID000000216
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	GPRASP1 PCLO DBT ALMS1 MKI67 MACF1 AKAP11 ZFYVE26 ANKRD12	9.85e-07	191	123	9	4168_DN
Drug	2-amino-4-chloro-6-hydroxy-s-triazine	TFAP2D TFAP2E TFAP2A TFAP2C	1.40e-06	16	123	4	CID000430167
Drug	NSC 308880	TFAP2D TFAP2E TFAP2A TFAP2C	1.83e-06	17	123	4	CID000073599
Disease	sleep disorder (implicated_via_orthology)	TFAP2D TFAP2E TFAP2A TFAP2C	7.58e-08	11	117	4	DOID:535 (implicated_via_orthology)
Disease	Colorectal Neoplasms	ABCA12 SYNE1 POLE GRIN2A PROM1 MKI67 KDM2A DCLK1	1.54e-05	277	117	8	C0009404
Disease	non-alcoholic fatty liver disease, cirrhosis of liver	PCSK5 SVIL MACROD2 DCLK1	5.92e-05	53	117	4	EFO_0001422, EFO_0003095
Disease	Malignant neoplasm of breast	TBC1D9B TFAP2D UBD SLCO2B1 SYNE1 SMC6 ELP3 TFAP2A ARFGAP3 SIPA1L1 MKI67 MACF1 ZFYVE26 BOD1L1	9.28e-05	1074	117	14	C0006142
Disease	Hepatitis, Animal	UBD LCN2	9.30e-05	4	117	2	C0019188
Disease	S-6-hydroxywarfarin measurement	LCORL PCLO KATNAL1 PARP14 PROM1 MACROD2 KMT2A MLLT3	1.14e-04	368	117	8	EFO_0803326
Disease	urate measurement, bone density	SYNE1 KATNAL1 FREM1 FSIP2 C11orf96 OLFM1 TTLL1 EIF2AK4 CABIN1 DCLK1	1.83e-04	619	117	10	EFO_0003923, EFO_0004531
Disease	platelet component distribution width	SYNE1 CNRIP1 KIF9 SVIL MACF1 MLLT3 TTLL1 C4BPA EIF2AK4 TGS1 XPO7	2.13e-04	755	117	11	EFO_0007984
Disease	male fertility, family size	PCSK5 MACROD2	2.31e-04	6	117	2	EFO_0004802, EFO_0004803
Disease	Abnormality of refraction	DNAJC13 LCORL PCLO GRIN2A KATNAL1 BIRC6 SLC25A12 MLLT3 VAV3 PCCA	3.56e-04	673	117	10	HP_0000539
Disease	obsolete_9,10-dihome measurement	LCORL ICE2	6.87e-04	10	117	2	EFO_0021572
Disease	central corneal thickness, intraocular pressure measurement	ZNF92 TANGO2	8.38e-04	11	117	2	EFO_0004695, EFO_0005213
Disease	alcohol consumption measurement	TFAP2D LCORL PCLO KATNA1 BIRC6 ALMS1 MACROD2 OLFM1 AKAP11 RPRD2 DCLK1 SENP7 XPO7	1.31e-03	1242	117	13	EFO_0007878
Disease	posterior thigh muscle volume	LCORL KDM2A	1.58e-03	15	117	2	EFO_0020931
Disease	Colorectal Carcinoma	MAP1B ABCA12 SYNE1 POLE GRIN2A PROM1 MKI67 KDM2A DCLK1	1.96e-03	702	117	9	C0009402
Disease	Eye Abnormalities	TFAP2A FREM1	2.04e-03	17	117	2	C0015393
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MKI67 OSBP2	2.12e-03	64	117	3	DOID:4947 (is_marker_for)
Disease	Disorder of organic acid metabolism	DBT PCCA	2.29e-03	18	117	2	cv:C1263739
Disease	sporadic amyotrophic lateral sclerosis	TFAP2A SLC25A12 MACROD2 ZFYVE26	2.38e-03	140	117	4	EFO_0001357
Disease	primary ciliary dyskinesia (implicated_via_orthology)	PCSK5 TTLL1	2.55e-03	19	117	2	DOID:9562 (implicated_via_orthology)
Disease	response to methotrexate, neurotoxicity	MACF1 PKN1	2.55e-03	19	117	2	EFO_0011057, GO_0031427
Disease	Bipolar Disorder	SYNE1 PCLO GRIN2A NEFM MLLT3 MBD5 DCLK1	2.98e-03	477	117	7	C0005586
Disease	risk-taking behaviour	LRRN1 LCORL CNRIP1 GRIN2A REV3L BIRC6 MACROD2 PCCA SENP7	3.44e-03	764	117	9	EFO_0008579
Disease	interleukin 18 measurement	BDP1 MAP1B BIRC6	3.46e-03	76	117	3	EFO_0004581
Disease	unipolar depression, bipolar disorder	NOL4 SYNE1 PCLO RPRD2	3.51e-03	156	117	4	EFO_0003761, MONDO_0004985
Disease	obsolete Mendelian syndromes with cleft lip/palate	SVIL PKN1	3.73e-03	23	117	2	MONDO_0015335
Disease	Huntington's disease (is_implicated_in)	GRIN2A CNTF	3.73e-03	23	117	2	DOID:12858 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
LTETRFKTGTTLKYT	C4BPA	66	P04003
YDRTAVKSLKSKSET	ERICH6B	281	Q5W0A0
DSKRLKTISYQLSVD	ERICH6	371	Q7L0X2
YSKIALDGKTTISST	BDP1	1806	A6H8Y1
LTESASTYRDIVVKK	CDY1	276	Q9Y6F8
SKEESIVSSLRLAYK	ARFGAP3	266	Q9NP61
LSLLSSTSKYKVTVA	TFAP2C	231	Q92754
SSKGSSSLDRLYSRK	BIRC6	2216	Q9NR09
SASKTEETLSKKREY	CATSPER2	426	Q96P56
EGTVKITDYSISKRL	EIF2AK4	436	Q9P2K8
LYVTDVKSASERPSK	BTLA	131	Q7Z6A9
SYGTKRKLSTALALI	ABCA12	2391	Q86UK0
DKTTVRKLQSYLETS	MLLT3	551	P42568
KDERKTVYTNTLLSS	CDKL3	326	Q8IVW4
DKTKTDYTRIKSLSI	ALMS1	3536	Q8TCU4
GRLSLLSSTSKYKVT	TFAP2A	216	P05549
SKLTRGLKDESLAYI	BIVM	306	Q86UB2
TTKSADRVTYAEKLS	AKAP11	1566	Q9UKA4
EAYESLVKSTTKRES	AMOTL1	481	Q8IY63
ESKSRVLKTELHYTG	ANKRD36B	1096	Q8N2N9
SYLLKSGADKEILTT	ANKRD40	61	Q6AI12
GRRNKTTYKVSSLSS	AHDC1	486	Q5TGY3
KELTRSKSSEVTDAY	ANKRD12	1136	Q6UB98
TGYKSSLREKDTATL	CADM3	136	Q8N126
LYLLKKSSTSVRDGG	DBF4	186	Q9UBU7
GRLSLLSSTSKYKVT	TFAP2D	216	Q7Z6R9
SLLSSTSKYKVTVGE	TFAP2E	226	Q6VUC0
YGFTLLSSKTADVTK	RCC1L	116	Q96I51
ITSVLRISSSKGYLK	OR9G1	221	Q8NH87
ASVTITSRYDGVIKK	DBT	106	P11182
SETTKIKRESTYSLT	MUC16	6936	Q8WXI7
VIRILSGSKDTKSYS	OR52N4	306	Q8NGI2
GSDEGYSSTSIKRIK	MXD1	196	Q05195
YEKIERTTKSPSDSG	MAP1B	1906	P46821
YDTTNRTGRSLKEKT	DST	6761	Q03001
STLEYKVKERSGTLK	LCORL	556	Q8N3X6
DEKSYSTSLKSRLTI	IGHV2-26	76	A0A0B4J1V2
IKTESGRYISSSYKR	DDX54	751	Q8TDD1
RTIYTIDGLKKISSL	DCLK1	106	O15075
GKKSERLELSYQSVS	CCDC88C	751	Q9P219
RISSPSDTKEKYRLT	FSIP2	961	Q5CZC0
SDTKEKYRLTGTRLS	FSIP2	966	Q5CZC0
SEKYSISRLTLEKQA	PCLO	4161	Q9Y6V0
SGESYDKKIITTDLR	PCSK5	361	Q92824
SYTRLGSVESSDKDK	OR3A4P	261	P47883
SSYTTILVKIRSKEG	OR4Q2	216	P0C623
LSGLSIEEYKTTLKI	PDE5A	701	O76074
KTETILKTRSLDYAG	OLFM1	326	Q99784
LTDTRSKIVYKSESA	FREM1	266	Q5H8C1
IKTRYADITVTSSKA	MACF1	1666	O94854
RSRSGYKKSSIEVSD	MPZL3	191	Q6UWV2
KLKLSGVVRLSSYSS	MOK	351	Q9UQ07
YGEQKSTSISTAKRL	POLE	1046	Q07864
ISSVKLVSRYGELKS	MKI67	206	P46013
AHSRTLSEEKYITSK	KIF9	226	Q9HAQ2
SKVKEYLVETSLRTG	MIER3	216	Q7Z3K6
KLITYGSDRTEALKR	PCCA	451	P05165
DSTKGATSIEKYDLR	KLHL5	476	Q96PQ7
EITISSKFRGKYISI	OSBP2	646	Q969R2
KGTTTIEKYDLRTNS	KLHL4	441	Q9C0H6
TKKTIERRYSDLTTL	MCM3	151	P25205
TLYGRTKELTSELKE	LCN2	156	P80188
TSGISIYRLLDKKTG	PCTP	36	Q9UKL6
DTSTTLSSIRSKYKV	PARP14	386	Q460N5
YKSDKDSTSTRLERK	BOD1L1	1001	Q8NFC6
KSTGRYRDEVSLKTA	DAAM1	266	Q9Y4D1
DSILKSTKYGEPITS	EFCAB5	676	A4FU69
LLIYKASDGKVTRTA	ICE2	871	Q659A1
LSEVEKAKIRGSYLT	KDM2A	786	Q9Y2K7
YSLLEDSTSDLRSKK	GPN3	196	Q9UHW5
PTSLLEGSRKSYTEK	CABIN1	1396	Q9Y6J0
TYSDLKSRDKDVTIV	DCLRE1C	601	Q96SD1
EKTRYDTSLGLLTKK	E2F2	126	Q14209
RTIKLLTGSSYKVEV	CNRIP1	36	Q96F85
KIRSDLTALTESYVK	CNTF	26	P26441
TLYALTSSTKIIKEA	DNAJC13	1836	O75165
TLTISIYDTKRNEKS	DRC7	711	Q8IY82
KYSERSLTKCIGITI	ELP3	206	Q9H9T3
KLKTLTEGLEAYSRV	MBD5	1426	Q9P267
YSVSERSFGSRTTKK	KMT2A	531	Q03164
STLTSKYRGESEKLV	KATNA1	276	O75449
SILKSSKLSDTTEYQ	RPRD2	856	Q5VT52
YLGLSKSSKEALSEV	SLC39A9	226	Q9NUM3
VKTSALDKNTSRTIY	RYK	201	P34925
TLSDKYKLSSEGTLE	LRRN1	471	Q6UXK5
GVILSSLKTYSQEKR	OR4A5	216	Q8NH83
KSLTEKVSLYRGDIT	MACROD2	66	A1Z1Q3
RESETKKGFYSLSVR	SLA	111	Q13239
RSKKEVYVESSSGSE	GPRASP1	286	Q5JY77
TLTSKYRGESEKLVR	KATNAL1	276	Q9BW62
VKYSDSKVELTLISR	SENP7	286	Q9BQF6
SGSSRSKSKDRKYTL	TAF10	181	Q12962
ETSDSSLEKQTRSKY	SVIL	61	O95425
RDLSTYSGKVSGLIK	SYNE1	3031	Q8NF91
SKVGSRYITKALSSV	OVCH1	306	Q7RTY7
RGVDASGETTYKKTT	PIP5K1C	61	O60331
TSSVIIEETKKYGRT	PROM1	731	O43490
KTRIISDGLKYSLAT	POLR2B	436	P30876
KYRAQLDTKTDSTGT	SIPA1L1	656	O43166
TYSNGSTKDRKLLLT	PKN1	151	Q16512
TSRGKESEDSSYKPI	SLF2	891	Q8IX21
LRTYGDSGKTKTVTR	NOL4	16	O94818
SKLDRIKTDYTLSIA	SERPINB12	101	Q96P63
KLKTSESSTILVVRY	SPANXC	41	Q9NY87
KSTGKYSLATEEIER	TBC1D9B	541	Q66K14
LEELSTKYSVDLTKG	ATP1A4	56	Q13733
YSTLAGTRKDVEVTK	SLC25A12	236	O75746
SASKGETYTLTLEHK	C11orf96	86	Q7Z7L8
GTTKEADAVSYKISR	ERVK-25	906	P63136
RSLSSYGIDKEKTIH	UBD	61	O15205
KGYSELDIVSERKSS	SPATA2	186	Q9UM82
SSNLTARKIIYTGEK	ZNF92	521	Q03936
SIGKLSEYRNSLESK	REV3L	1396	O60673
TELGYKEKLTFTEST	SLFN12L	206	Q6IEE8
SGYLKSSISTVEKRF	SLCO2B1	66	O94956
KLKTSESSTILVVRY	SPANXD	41	Q9BXN6
KYTRSSLLRETESKS	STYXL2	961	Q5VZP5
ISIDGSRSYKLKSAT	SMC6	146	Q96SB8
SRSYKLKSATGSVVS	SMC6	151	Q96SB8
SIGYSSVRKLVKLSA	XPO7	621	Q9UIA9
GTTKEADAVSYKISR	ERVK-19	911	Q9WJR5
TRTYELQSKKDTETE	TGS1	166	Q96RS0
IYLQETSRSSGRKKT	ZFYVE26	2301	Q68DK2
STRTTYKKIDAGEKR	ZNF506	186	Q5JVG8
RLYLESTRGKEVTSK	TTLL1	266	O95922
EKYRTSLEKALGISS	TRIO	1236	O75962
LTTDVDSLSYLKKVS	TANGO2	96	Q6ICL3
ESAISSLDYISKTKE	VAV3	286	Q9UKW4
VERTYLKTKSSSPRD	GRIN2A	1101	Q12879
YLKTDISTALKEIRS	NEFM	261	P07197